$ELDN News

Eledon Pharma To Highlight New Clinical Data From Tegoprubart Program In Patients Undergoing Kidney Transplantation In Oral And Poster Presentation At ATC 2026

Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights

Eledon Pharma Q1 EPS $(0.33) Misses $(0.18) Estimate

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug

Eledon Pharmaceuticals Files Prospectus For Offering $500M Securities

Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money

Eledon Pharmaceuticals Inc (NASDAQ:ELDN) Reports Narrower Q4 Loss and Positive Clinical Data for Tegoprubart

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Eledon Pharma Q4 EPS $(0.10) Beats $(0.18) Estimate

Eledon Pharmaceuticals: Tegoprubart Continues To Shine As Immunosuppressive Alternative

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine

Eledon Pharmaceuticals Says Investigator-Initiated Islet Transplant Trial Of Tegoprubart For Diabetes Shows 100% Insulin Independence Achieved In 10 Patients Who Are Over 4 Weeks Post-transplant

Eledon Pharmaceuticals Touts Tegoprubart Safety in BESTOW Kidney Transplant Data at Leerink Conference

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation

NewcelX and Eledon partner for NCEL-101 programme

Eledon Says FDA Grants Orphan Drug Designation To Tegoprubart For Prevention Of Allograft Rejection In Liver Transplantation

Eledon Says FDA Grants Orphan Drug Designation To Tegoprubart For Prevention Of Allograft Rejection In Liver Transplantation

Newcelx Announces Collaborative Research Agreement With Eledon Pharmaceuticals To Advance The NCEL-101 Program For Type 1 Diabetes

Eledon Pharmaceuticals Granted Orphan Designation For Tegoprubart, For Prevention Of Allograft Rejection In Liver Transplantation

Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference